Tender Results of The Common Services Agency More Commonly Known As Nhs National Services Scotland Nss

NP502423b SWAN NHS Call off contract-Award against framework: NP502423 SWAN Framework (SC Ref:740581) This Call off contract from the SWAN framework to provide wide area network connectivity services and related additional services to all NHS Boards in Scotland.

National Mental Health CCBT Software-NHS National Services Scotland (NHS NSS) has procured Computerised Cognitive Behaviour Therapy (CCBT) software on behalf of Scottish Government. The contract is split into 2 lots, Generalised Anxiety Disorder and Insomnia.

National Mental Health CCBT Software-NHS National Services Scotland (NHS NSS) has procured Computerised Cognitive Behaviour Therapy (CCBT) software on behalf of Scottish Government. The contract is split into 2 lots, Generalised Anxiety Disorder and Insomnia. The values provided in II.1.7 and V.2.4 include the initial 60 month contract period and the 24 month optional extension period(s). (SC Ref:740403)

National Mental Health CCBT Software-The values provided in II.1.7 and V.2.4 include the initial 60 month contract period and the 24 month optional extension period(s). (SC Ref:740403) NHS National Services Scotland (NHS NSS) has procured Computerised Cognitive Behaviour Therapy (CCBT) software on behalf of Scottish Government. The contract is split into 2 lots, Generalised Anxiety Disorder and Insomnia.

NP94023a-d Ellipta Inhalers-Total value of the procurement (II.1.7 and V.2.4) covers the forty-eight (48) month contract duration and the twelve (12) month extension period of the Framework Agreements. (SC Ref:740091) Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro® Ellipta®) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse® Ellipta®) NP94023c: Fluticasone furoate 184micrograms/dose /...

NP94023a-d Ellipta Inhalers-Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro® Ellipta®) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse® Ellipta®) NP94023c: Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023c: Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023d: Flutic...

NP33923 Ranibizumab-Supply of ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes and ranibizumab 2.3mg/0.23ml solution for injection vials to NHS Scotland. This has been awarded as an unranked multi supplier framework agreement.

NP33923 Ranibizumab-Supply of ranibizumab injections to NHS Scotland The estimated value referred to in Section II.1.7 and V.2.4 covers the twelve (12) month initial duration and the thirty six (36) month extension period of the framework agreement. (SC Ref:739925)

NP33923 Ranibizumab-The estimated value referred to in Section II.1.7 and V.2.4 covers the twelve (12) month initial duration and the thirty six (36) month extension period of the framework agreement. (SC Ref:739925) Supply of ranibizumab injections to NHS Scotland

Clinical Apheresis-Lot 1 & 2 are for Therapeutic Apheresis (Cell Separator) machines, operating software, maintenance and associated kits / consumables. Therapeutic Apheresis to include – - Cell collection - Plasma exchange - Red cell exchange - Red cell depletion/exchange - Platelet reduction - White cell reduction. SNBTS perform approximately 1,500 therapeutic procedures per annum. - Approximately 70% of procedures are made up of exchanges, - App...